3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioma
3
Glioblastoma
3
Astrocytoma
2
Whooping Cough
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Measles
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Gliosarcoma
1
Carcinoma
1
Advanced Cancer
1
Interventions
Filgrastim
19
Temozolomide
18
Cyclophosphamide
16
Carboplatin
15
Etoposide
12
Vincristine
11
Peripheral Blood Stem Cell Transplantation
10
Cisplatin
10
Radiotherapy
9
Irinotecan
9
Thiotepa
8
Granulocyte Colony-Stimulating Factor
7
sonidegib
5
Methotrexate
5
sargramostim
4
Vorinostat
4
Magnetic Resonance Spectroscopy
4
Lomustine
4
Chemotherapy, Adjuvant
4
Carmustine
4
etoposide phosphate
3
Topotecan
3
Radiation
3
Platinum
3
Paclitaxel
3
Oxaliplatin
3
O(6)-benzylguanine
3
Melphalan
3
HhAntag691
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Medulloblastoma
×
Tetanus Toxoid
×
Clear all
NCT03615404
2021-01-28
ATTAC-P
Duke University
Phase 1
Completed
11 enrolled
7 charts